CGS 19755 is a potent and competitive antagonist at NMDA-type receptors
Authors:
- A.G. ChapmanACA.G. Chapman
- B.S. MeldrumBMB.S. Meldrum
- A. HutchisonAHA. Hutchison
- C. TsaiCTC. Tsai
- P.L. WoodPWP.L. Wood
- 1 September 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 154 (1) , 89-93
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbilsBrain Research, 1988
- Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonistEuropean Journal of Pharmacology, 1987
- CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.The Journal of Pharmacology and Experimental Therapeutics, 1987
- Action of 3-((±)-2-car☐ypiperazin-4-yl)-propyl-1-phosphonic aci (CPP): a new and highly potent antagonist of N-methyl-d-aspartate receptors in the hippocampusBrain Research, 1986
- Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slicesBrain Research, 1982
- Antagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellumNeuropharmacology, 1982
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982
- 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitationNeuroscience Letters, 1981
- EARLY AND LATE MECHANISMS OF INCREASED VASCULAR PERMEABILITY FOLLOWING EXPERIMENTAL CEREBRAL INFARCTIONJournal of Neuropathology & Experimental Neurology, 1979